市場調查報告書

CAR-T細胞療法的全球市場

Global Market Study on CAR T-cell Therapy: The Future of Cancer Treatment

出版商 Persistence Market Research 商品編碼 917609
出版日期 內容資訊 英文 150 Pages
商品交期: 2-3個工作天內
價格
CAR-T細胞療法的全球市場 Global Market Study on CAR T-cell Therapy: The Future of Cancer Treatment
出版日期: 2019年11月13日內容資訊: 英文 150 Pages
簡介

本報告提供全球CAR-T細胞療法市場的相關調查,市場機會,成長及阻礙因素,各產品類型、適應症、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 市場概要

  • 市場調查範圍/分類
  • 市場定義/範圍/限制

第3章 主要成功因素

  • 冰山分析
  • 商機分析
  • 親市場分析
  • 開發平台評估
  • CAR-T細胞療法合格的潛在的人口:各地區
  • 美國、英國的認證治療中心的清單
  • 主要的內涵/排除

第4章 市場需求(銷售額/規模)分析及預測

  • 過去的市場分析
  • 現在、今後的市場預測
    • 與前一年同期比較成長趨勢分析

第5章 市場背景

  • 宏觀經濟要素
    • 醫療費的增加
    • 為實施研究作為主要組織的學界的出現
    • 識別治療困難疾病的治療方法的共同的配合措施及舉措
  • 預測要素:相關及影響
    • CAR-T細胞療法的可用性提高
    • CAR-T細胞療法的採用增加
    • 出色的產品效率
    • 償付方案的改善
    • 製藥公司和生物製藥公司間的合作
  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會分析

第6章 市場分析:各產品類型

  • 簡介/主要調查結果
  • 過去的市場分析
  • 現在、今後的市場分析、預測
    • Yescarta (axicabtagene ciloleucel)
    • Kymriah (tisagenlecleucel)
    • JCAR017(lisocabtagene maraleucel)
    • BB2121
  • 市場魅力分析

第7章 市場分析:各適應症

  • 簡介/主要調查結果
  • 過去的市場分析
  • 現在、今後的市場分析、預測
    • 復發的大細胞型B細胞淋巴瘤
    • 急性淋巴芽球性白血病(ALL)
    • 多發性骨髓瘤
  • 市場魅力分析

第8章 市場分析:各終端用戶

  • 簡介/主要調查結果
  • 過去的市場分析
  • 現在、今後的市場分析、預測
    • 醫院
    • 癌症治療中心
  • 市場魅力分析

第9章 市場分析:各地區

  • 簡介
  • 過去的市場規模
  • 目前市場分析、預測
    • 北美
    • 歐洲
    • 日本
  • 市場魅力分析:各地區

第10章 北美

  • 簡介
  • 過去的市場分析:各市場分類法
  • 市場預測:各市場分類法
    • 各國
    • 各產品類型
    • 表示
    • 各終端用戶
  • 市場魅力分析
  • 主要市場參與企業:強度製圖
  • 成長及阻礙因素:影響分析

第11章 歐洲

第12章 日本

第13章 市場結構分析

  • 市場分析:企業的各等級
  • 主要企業的市場佔有率分析
  • 市場影響分析
    • 企業的成果:各地區
    • 產品的成果:各企業
    • 流通管道的成果:各企業

第14章 競爭情形

  • 競爭儀表板
  • 價格分析:各競爭
  • 競爭基準
  • 企業簡介
    • Novartis AG
    • Gilead Sciences Inc.
    • Celgene Corporation
    • bluebird bio, Inc.

第15章 前提條件及簡稱的使用

第16章 調查方法

目錄

CAR T-Cell Therapy Market - Scope of the Report

Persistence Market Research (PMR) recently published a market study on the global market for CAR T-cell therapy. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities restraints, and detailed information about the CAR T-cell therapy market structure. The market study presents exclusive information about how the CAR T-cell therapy market will grow during the forecast period 2019 - 2026.

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market, and compounded annual growth rate (CAGR) are explained in PMR's study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the CAR T-cell therapy market during the forecast period.

The study is relevant for stakeholders in the CAR T-cell therapy market, including CAR T-cell therapy products manufactures, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Stakeholders in the CAR T-cell therapy market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in PMR's study.

The study also includes statistics as well as facts related to macroeconomic factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the CAR T-cell therapy market. Furthermore, small businesses and new entrants in the CAR T-cell therapy market too can make use of the information presented in this study, based on, which they can make appropriate business decisions to gain momentum in the CAR T-cell therapy market.

Key Questions Answered in PMR's CAR T-Cell Therapy Market Report

  • Which regions will continue to remain the most profitable regional markets for CAR T-cell therapy market players?
  • Which factors will essentially induce a change in the demand for CAR T-cell therapy in the forecast period?
  • How will changing trends impact the CAR T-cell therapy market?
  • What are key manufacturers' strategy to enhance their product adoption and improve regional product footprints?
  • Which companies are leading the CAR T-cell therapy market?
  • What are the winning strategies of stakeholders in the CAR T-cell therapy market to upscale their position in this landscape?

CAR T-Cell Therapy Market: Research Methodology

In PMR's study, a unique research methodology is utilized to conduct extensive research on the growth of the CAR T-cell therapy market, and reach conclusions on future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of conclusions.

Secondary resources referred to analysts during the production of the CAR T-cell therapy market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the CAR T-cell therapy market, and makes PMR's projection on the growth prospects of the CAR T-Cell therapy market more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Key Market Trends
  • 1.3. Market Share Analysis, By Taxonomy
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Success Factors

  • 3.1. Iceberg Analysis
  • 3.2. Revenue Opportunity Analysis
  • 3.3. Parent Market Analysis
  • 3.4. Pipeline Assessment
  • 3.5. Potential Population Eligible for CAR T-cell Therapy, By Region
  • 3.6. List of Authorized Treatment Centers in the U.S. & U.K.
  • 3.7. Key Inclusion & Exclusion

4. Global CAR T-Cell Therapy Market Demand (in Value or Size in US$ Mn) Analysis 2017-2018 and Forecast, 2019-2026

  • 4.1. Historical Market Value (US$ Mn) Analysis, 2017-2018
  • 4.2. Current and Future Market Value (US$ Mn) Projections, 2019-2026
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Increase in Healthcare Spending
    • 5.1.2. Emergence of Academia as the Primary Organization for Carrying Out Research
    • 5.1.3. Collaborative Efforts and Initiatives to Identify Therapies for Difficult-To-Treat Illnesses
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increasing Availability of CAR T-cell Therapy
    • 5.2.2. Increasing Adoption of CAR T-cell Therapy
    • 5.2.3. Superior Product Efficacy
    • 5.2.4. Improving Reimbursement Scenario
    • 5.2.5. Collaboration among Pharmaceutical and Biopharmaceutical Companies
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. Global CAR T-Cell Therapy Market Analysis 2017-2018 and Forecast 2019-2026, by Product Type

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size (US$ Mn) and Analysis By Product Type, 2017-2018
  • 6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019-2026
    • 6.3.1. Yescarta (axicabtagene ciloleucel)
    • 6.3.2. Kymriah (tisagenlecleucel)
    • 6.3.3. JCAR017 (lisocabtagene maraleucel)
    • 6.3.4. bb2121 Market Attractiveness Analysis By Product Type

7. Global CAR T-Cell Therapy Market Analysis 2017-2018 and Forecast 2019-2026, by Indication

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Mn) Analysis By Indication, 2017-2018
  • 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2019-2026
    • 7.3.1. Relapsed Large B-cell Lymphoma
    • 7.3.2. Acute Lymphoblastic Leukemia (ALL)
    • 7.3.3. Multiple Myeloma
  • 7.4. Market Attractiveness Analysis By Indication

8. Global CAR T-Cell Therapy Market Analysis 2017-2018 and Forecast 2019-2026, by End User

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By End User, 2017-2018
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019-2026
    • 8.3.1. Hospitals
    • 8.3.2. Cancer Treatment Centers
  • 8.4. Market Attractiveness Analysis By End User

9. Global CAR T-Cell Therapy Market Analysis 2017-2018 and Forecast 2019-2026, by Region

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn Analysis By Region, 2017-2018
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019-2026
    • 9.3.1. North America
    • 9.3.2. Europe
    • 9.3.3. Japan
  • 9.4. Market Attractiveness Analysis By Region

10. North America CAR T-Cell Therapy Market Analysis 2017-2018 and Forecast 2019-2026

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2018
  • 10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2026
    • 10.3.1. By Country
      • 10.3.1.1. U.S.
      • 10.3.1.2. Canada
    • 10.3.2. By Product Type
    • 10.3.3. By Indication
    • 10.3.4. By End User
  • 10.4. Market Attractiveness Analysis
  • 10.5. Key Market Participants - Intensity Mapping
  • 10.6. Drivers and Restraints - Impact Analysis

11. Europe CAR T-Cell Therapy Market Analysis 2017-2018 and Forecast 2019-2026

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2018
  • 11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2026
    • 11.3.1. By Country
      • 11.3.1.1. Germany
      • 11.3.1.2. Italy
      • 11.3.1.3. France
      • 11.3.1.4. U.K.
      • 11.3.1.5. Spain
      • 11.3.1.6. Rest of Europe
    • 11.3.2. By Product Type
    • 11.3.3. By Indication
    • 11.3.4. By End User
  • 11.4. Market Attractiveness Analysis
  • 11.5. Key Market Participants - Intensity Mapping
  • 11.6. Drivers and Restraints - Impact Analysis

12. Japan CAR T-Cell Therapy Market Analysis 2017-2018 and Forecast 2019-2026

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2018
  • 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2026
    • 12.3.1. By Product Type
    • 12.3.2. By Indication
    • 12.3.3. By End User
  • 12.4. Market Attractiveness Analysis
  • 12.5. Key Market Participants - Intensity Mapping
  • 12.6. Drivers and Restraints - Impact Analysis

13. Market Structure Analysis

  • 13.1. Market Analysis by Tier of Companies (CAR T-Cell Therapy)
  • 13.2. Market Share Analysis of Top Players
  • 13.3. Market Presence Analysis
    • 13.3.1. By Regional footprint of Players
    • 13.3.2. Treatment foot print by Players
    • 13.3.3. Channel Foot Print by Players

14. Competition Analysis

  • 14.1. Competition Dashboard
  • 14.2. Pricing Analysis by Competition
  • 14.3. Competition Benchmarking
  • 14.4. Competition Deep Dive
    • 14.4.1. Novartis AG
      • 14.4.1.1. Overview
      • 14.4.1.2. Drug Portfolio
      • 14.4.1.3. Profitability by Market Segments (Drug/Channel/Region)
      • 14.4.1.4. Sales Footprint
      • 14.4.1.5. Strategy Overview
        • 14.4.1.5.1. Marketing Strategy
        • 14.4.1.5.2. Drug Strategy
        • 14.4.1.5.3. Channel Strategy
    • 14.4.2. Gilead Sciences Inc.
      • 14.4.2.1. Overview
      • 14.4.2.2. Drug Portfolio
      • 14.4.2.3. Profitability by Market Segments (Drug/Channel/Region)
      • 14.4.2.4. Sales Footprint
      • 14.4.2.5. Strategy Overview
        • 14.4.2.5.1. Marketing Strategy
        • 14.4.2.5.2. Drug Strategy
        • 14.4.2.5.3. Channel Strategy
    • 14.4.3. Celgene Corporation
      • 14.4.3.1. Overview
      • 14.4.3.2. Drug Portfolio
      • 14.4.3.3. Profitability by Market Segments (Drug/Channel/Region)
      • 14.4.3.4. Sales Footprint
      • 14.4.3.5. Strategy Overview
        • 14.4.3.5.1. Marketing Strategy
        • 14.4.3.5.2. Drug Strategy
        • 14.4.3.5.3. Channel Strategy
    • 14.4.4. bluebird bio, Inc.
      • 14.4.4.1. Overview
      • 14.4.4.2. Drug Portfolio
      • 14.4.4.3. Profitability by Market Segments (Drug/Channel/Region)
      • 14.4.4.4. Sales Footprint
      • 14.4.4.5. Strategy Overview
        • 14.4.4.5.1. Marketing Strategy
        • 14.4.4.5.2. Drug Strategy
        • 14.4.4.5.3. Channel Strategy

15. Assumptions and Acronyms Used

16. Research Methodology

List of Tables

  • Table 01: CAR T-Cell Therapy, Pipeline Assessment
  • Table 02: CAR T-Cell Therapy, Pipeline Assessment
  • Table 03: CAR T-Cell Therapy, Pipeline Assessment
  • Table 04: CAR T-Cell Therapy, Pipeline Assessment
  • Table 05: CAR T-Cell Therapy, Pipeline Assessment
  • Table 06: CAR T-Cell Therapy, Pipeline Assessment
  • Table 07: CAR T-Cell Therapy, Pipeline Assessment
  • Table 08: CAR T-Cell Therapy, Pipeline Assessment
  • Table 09: CAR T-Cell Therapy, Pipeline Assessment
  • Table 10: CAR T-Cell Therapy, Pipeline Assessment
  • Table 11: CAR T-Cell Therapy, Pipeline Assessment
  • Table 12: CAR T-Cell Therapy, Pipeline Assessment
  • Table 13: CAR T-Cell Therapy, Pipeline Assessment
  • Table 14: CAR T-Cell Therapy, Pipeline Assessment
  • Table 15: CAR T-Cell Therapy, Pipeline Assessment
  • Table 16: CAR T-Cell Therapy, Pipeline Assessment
  • Table 17: CAR T-Cell Therapy, Pipeline Assessment
  • Table 18: CAR T-Cell Therapy, Pipeline Assessment
  • Table 19: CAR T-Cell Therapy, Pipeline Assessment
  • Table 20: CAR T-Cell Therapy, Pipeline Assessment
  • Table 21: CAR T-Cell Therapy, Pipeline Assessment
  • Table 22: CAR T-Cell Therapy, Pipeline Assessment
  • Table 23: CAR T-Cell Therapy, Pipeline Assessment
  • Table 24: CAR T-Cell Therapy, Pipeline Assessment
  • Table 25: CAR T-Cell Therapy, Pipeline Assessment
  • Table 26: CAR T-Cell Therapy, Pipeline Assessment
  • Table 27: Treatment Centers Authorized to Administer CAR T-Cell Therapy in the U.S.
  • Table 28: Treatment Centers Authorized to Administer CAR T-Cell Therapy in the U.S.
  • Table 29: Treatment Centers Authorized to Administer CAR T-Cell Therapy in the U.S.
  • Table 30: Treatment Centers Authorized to Administer CAR T-Cell Therapy in the U.S.
  • Table 31: Treatment Centers Authorized to Administer CAR T-Cell Therapy in the U.K.
  • Table 32: Global CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Product Type
  • Table 33: Global CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Indication
  • Table 34: Global CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By End User
  • Table 35: Global CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Region
  • Table 36: North America CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Country
  • Table 37: North America CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Product Type
  • Table 38: North America CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Indication
  • Table 39: North America CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By End User
  • Table 40: Europe CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Country
  • Table 41: Europe CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Product Type
  • Table 42: Europe CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Indication
  • Table 43: Europe CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By End User
  • Table 44: Japan CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Product Type
  • Table 45: Japan CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Indication
  • Table 46: Japan CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By End User

List of Figures

  • Figure 01: CAR T-Cell Therapy Market Value ($ Mn), By Country, 2018 & 2026
  • Figure 02: Global CAR T-Cell Therapy Market Value Share By Product Type (2019E)
  • Figure 03: Global CAR T-Cell Therapy Market Value Share By Indication (2019E)
  • Figure 04: Global CAR T-Cell Therapy Market Value Share By End User (2019E)
  • Figure 05: Global CAR T-Cell Therapy Market Value Share By Region (2019E)
  • Figure 06: CAR T-Cell Therapy, Pipeline Assessment
  • Figure 07: Global CAR T-Cell Therapy Market Value Analysis (US$ Mn), 2017-2018
  • Figure 08: Global CAR T-Cell Therapy Market Value Analysis (US$ Mn), 2019-2026
  • Figure 09: Global CAR T-Cell Therapy Market Absolute $ Opportunity, 2017-2018
  • Figure 10: Global CAR T-Cell Therapy Market Absolute $ Opportunity, 2019-2026
  • Figure 11: Global CAR T-Cell Therapy Market Share Analysis (%) By Product Type, 2019 & 2026
  • Figure 12: Global CAR T-Cell Therapy Market Y-o-Y Growth (%) By Product Type, 2019-2026
  • Figure 13: Global CAR T-Cell Therapy Market Attractiveness Analysis, By Product Type
  • Figure 14: Global CAR T-Cell Therapy Market Share Analysis (%) By Indication, 2019 & 2026
  • Figure 15: Global CAR T-Cell Therapy Market Y-o-Y Growth (%) By Indication, 2019-2026
  • Figure 16: Global CAR T-Cell Therapy Market Attractiveness Analysis, By Indication
  • Figure 17: Global CAR T-Cell Therapy Market Share Analysis (%) By End User, 2019 & 2026
  • Figure 18: Global CAR T-Cell Therapy Market Y-o-Y Growth (%) By End User, 2019-2026
  • Figure 19: Global CAR T-Cell Therapy Market Attractiveness Analysis, By End User
  • Figure 20: Global CAR T-Cell Therapy Market Share Analysis (%) By Region, 2019 & 2026
  • Figure 21: Global CAR T-Cell Therapy Market Y-o-Y Growth (%) By Region, 2019-2026
  • Figure 22: Global CAR T-Cell Therapy Market Attractiveness Analysis, By Region
  • Figure 23: North America CAR T-Cell Therapy Market Size (US$ Mn), 2017-2018
  • Figure 24: North America CAR T-Cell Therapy Market Size (US$) & Y-o-Y Growth (%), 2019-2026
  • Figure 25: North America CAR T-Cell Therapy Market Analysis by Country - 2019 & 2026
  • Figure 26: North America CAR T-Cell Therapy Market Y-o-Y Growth Projections by Country, 2019-2026
  • Figure 27: North America CAR T-Cell Therapy Market Attractiveness Analysis by Country, 2019-2026
  • Figure 28: North America CAR T-Cell Therapy Market Analysis by Product Type - 2019 & 2026
  • Figure 29: North America CAR T-Cell Therapy Market Y-o-Y Growth Projections by Product Type, 2019-2026
  • Figure 30: North America CAR T-Cell Therapy Market Attractiveness Analysis by Product Type, 2019-2026
  • Figure 31: North America CAR T-Cell Therapy Market Analysis by Indication -2019 & 2026
  • Figure 32: North America CAR T-Cell Therapy Market Y-o-Y Growth Projections by Indication, 2019-2026
  • Figure 33: North America CAR T-Cell Therapy Market Attractiveness Analysis by Indication, 2019-2026
  • Figure 34: North America CAR T-Cell Therapy Market Analysis by End User -2019 & 2026
  • Figure 35: North America CAR T-Cell Therapy Market Y-o-Y Growth Projections by End User, 2019-2026
  • Figure 36: North America CAR T-Cell Therapy Market Attractiveness Analysis by End User, 2019-2026
  • Figure 37: Europe CAR T-Cell Therapy Market Size (US$ Mn), 2017-2018
  • Figure 38: Europe CAR T-Cell Therapy Market Size (US$) & Y-o-Y Growth (%), 2019-2026
  • Figure 39: Europe CAR T-Cell Therapy Market Analysis by Country - 2019 & 2026
  • Figure 40: Europe CAR T-Cell Therapy Market Y-o-Y Growth Projections by Country, 2019-2026
  • Figure 41: Europe CAR T-Cell Therapy Market Attractiveness Analysis by Country, 2019-2026
  • Figure 42: Europe CAR T-Cell Therapy Market Analysis by Product Type - 2019 & 2026
  • Figure 43: Europe CAR T-Cell Therapy Market Y-o-Y Growth Projections by Product Type, 2019-2026
  • Figure 44: Europe CAR T-Cell Therapy Market Attractiveness Analysis by Product Type, 2019-2026
  • Figure 45: Europe CAR T-Cell Therapy Market Analysis by Indication -2019 & 2026
  • Figure 46: Europe CAR T-Cell Therapy Market Y-o-Y Growth Projections by Indication, 2019-2026
  • Figure 47: Europe CAR T-Cell Therapy Market Attractiveness Analysis by Indication, 2019-2026
  • Figure 48: Europe CAR T-Cell Therapy Market Analysis by End User -2019 & 2026
  • Figure 49: Europe CAR T-Cell Therapy Market Y-o-Y Growth Projections by End User, 2019-2026
  • Figure 50: Europe CAR T-Cell Therapy Market Attractiveness Analysis by End User, 2019-2026
  • Figure 51: Japan CAR T-Cell Therapy Market Size (US$ Mn), 2017-2018
  • Figure 52: Japan CAR T-Cell Therapy Market Size (US$) & Y-o-Y Growth (%), 2019-2026
  • Figure 53: Japan CAR T-Cell Therapy Market Analysis by Product Type - 2019 & 2026
  • Figure 54: Japan CAR T-Cell Therapy Market Y-o-Y Growth Projections by Product Type, 2019-2026
  • Figure 55: Japan CAR T-Cell Therapy Market Attractiveness Analysis by Product Type, 2019-2026
  • Figure 56: Japan CAR T-Cell Therapy Market Analysis by Indication -2019 & 2026
  • Figure 57: Japan CAR T-Cell Therapy Market Y-o-Y Growth Projections by Indication, 2019-2026
  • Figure 58: Japan CAR T-Cell Therapy Market Attractiveness Analysis by Indication, 2019-2026
  • Figure 59: Japan CAR T-Cell Therapy Market Analysis by End User -2019 & 2026
  • Figure 60: Japan CAR T-Cell Therapy Market Y-o-Y Growth Projections by End User, 2019-2026
  • Figure 61: Japan CAR T-Cell Therapy Market Attractiveness Analysis by End User, 2019-2026
  • Figure 62: Company Market Share Analysis, 2018